Sai Life Sciences’ Screening Capabilities Enhanced with Expanded Cellular Analysis Platforms
October 7th 2020Following a recent expansion at its Cambridge, MA, facility, the company now houses a new suite of cellular analysis platforms that enhance its exploratory capabilities into oncology, neuroscience, and rare diseases.
2 Commerce Drive
Cranbury, NJ 08512